
Σταδιοποίηση σε Ca Θυρεοειδούς Αδένα
Ca Θυρεοειδούς Αδένα |
||||
AJCC Stages – Θηλώδης ή Θηλακιώδης (διαφοροποιημένο) |
||||
< 45 ετών |
T |
N |
M |
|
I |
Any T |
Any N |
M0 |
|
II |
Any T |
Any N |
M1 |
|
> 45 ετών |
T |
N |
M |
|
I |
T1 |
N0 |
M0 |
|
II |
T2 |
N0 |
M0 |
|
III |
T3 |
N0 |
M0 |
|
T1, T2, T3 |
N1a |
M0 |
||
IVA |
T4a |
N0 |
M0 |
|
T4a |
N1a |
M0 |
||
T1, T2, T3, T4a |
N1b |
M0 |
||
IVB |
T4b |
Any N |
M0 |
|
IVC |
Any T |
Any N |
M1 |
|
AJCC Stages – Μυελοειδής (ανεξαρτήτως ηλικίας) |
||||
I |
T1 |
N0 |
M0 |
|
II |
T2 |
N0 |
M0 |
|
T3 |
N0 |
M0 |
||
III |
T1, T2, T3 |
N1a |
M0 |
|
IVA |
T4a |
N0 |
M0 |
|
T4a |
N1a |
M0 |
||
T1, T2, T3, T4a |
N1b |
M0 |
||
IVB |
T4b |
Any N |
M0 |
|
IVC |
Any T |
Any N |
M1 |
|
AJCC Stages – Αναπλαστικός |
||||
IVA |
T4a |
Any N |
M0 |
|
IVB |
T4b |
Any N |
M0 |
|
IVC |
Any T |
Any N |
M1 |
|
(T) Primary Tumor |
||||
TX |
Primary tumor cannot be assessed |
|||
T0 |
No evidence of primary tumor |
|||
T1 |
Tumor ≤ 2 cm in greatest dimension limited to the thyroid |
|||
T1a |
Tumor ≤ 1 cm, limited to the thyroid |
|||
T1b |
Tumor > 1 cm but ≤ 2 cm in greatest dimension, limited to the thyroid |
|||
T2 |
Tumor > 2 cm but ≤ 4 cm in greatest dimension, limited to the thyroid |
|||
T3 |
Tumor > 4 cm in greatest dimension, limited to the thyroid or any tumor with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues) |
|||
T4 |
|
|||
T4a |
Moderately advanced disease: Tumor of any size extending beyond the thyroid capsule to invade the subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve |
|||
T4b |
Very advanced disease: Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels |
|||
Anaplastic carcinoma with gross extrathyroid extension |
||||
Αναπλαστικό |
|
|||
T4a |
Intrathyroidal anaplastic carcinoma |
|||
T4b |
Anaplastic carcinoma with gross extrathyroid extension |
|||
All (T) categories may be subdivided into (s) solitary tumor and (m) multifocal tumor; the largest determines the classification. |
||||
(N) Regional Lymph Nodes |
||||
NX |
Regional lymph nodes cannot be assessed |
|||
N0 |
No regional lymph node metastasis² |
|||
N1 |
Regional lymph node metastasis² |
|||
N1a |
Metastasis to level VI (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes) |
|||
N1b |
Metastasis to unilateral, bilateral, or contralateral cervical (levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (level VII) |
|||
²Regional lymph nodes are the central compartment, lateral cervical, and upper mediastinal lymph nodes. |
||||
(M) Distant Metastasis |
||||
M0 |
No distant metastasis |
|||
M1 |
Distant metastasis |
|||
Χαρακτηριστικά Επέκτασης |
||||
Differentiated thyroid carcinoma (DTC)
|
Multiple sites Medullary thyroid carcinoma (MTC)
Anaplastic carcinoma
|
|||
Κατηγοριοποίηση (Ιστολογικοί Τύποι) |
||||
Primary malignant tumors(WHO classification)
|
|